These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 426503)

  • 41. Pharmacokinetics of amoxycillin and ampicillin in patients with renal failure.
    Ksiazek A; Twardowski Z; Przyborowski L; Majdan M; Sokołowska G; Hopkała H; Solski J; Zbikowska A; Misztal G; Bocheńska-Nowacka E
    Ann Univ Mariae Curie Sklodowska Med; 1983; 38():79-86. PubMed ID: 6600085
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of renal impairment on the pharmacokinetics and tolerability of tiagabine.
    Cato A; Gustavson LE; Qian J; El-Shourbagy T; Kelly EA
    Epilepsia; 1998 Jan; 39(1):43-7. PubMed ID: 9578011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of parenterally administered amoxycillin.
    Hill SA; Jones KH; Lees LJ
    J Infect; 1980 Dec; 2(4):320-32. PubMed ID: 7185932
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical evaluation of amoxicillin tablets (Widecillin tablets) in pediatric field (author's transl)].
    Nakazawa S; Sato H; Kojima S; Hirama Y; Chikaoka S; Kanda S; Yamaguchi T
    Jpn J Antibiot; 1978 Oct; 31(10):601-5. PubMed ID: 731857
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetics of cefaclor in normal subjects and patients with chronic renal failure.
    Bloch R; Szwed JJ; Sloan RS; Luft FC
    Antimicrob Agents Chemother; 1977 Dec; 12(6):730-2. PubMed ID: 931372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacodynamics of cefazolin in the presence of normal and impaired renal function.
    Rein MF; Westervelt FB; Sande MA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):366-71. PubMed ID: 4758839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of aspoxicillin in subjects with normal and impaired renal function.
    Geyer J; Höffler D; Koeppe P
    Arzneimittelforschung; 1988 Nov; 38(11):1635-9. PubMed ID: 3214450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.
    Mihindu JC; Scheld WM; Bolton ND; Spyker DA; Swabb EA; Bolton WK
    Antimicrob Agents Chemother; 1983 Aug; 24(2):252-61. PubMed ID: 6685452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mathematical modeling of ampicillin pharmacokinetics in patients with altered excretory function of the kidneys].
    Manuĭlov KK
    Antibiot Khimioter; 1991 Aug; 36(8):42-4. PubMed ID: 1755710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical investigation of amoxicillin (clamoxyl 'Beecham') granules in pediatrics (author's transl)].
    Nakazawa S; Sato H; Fujii S; Kohima S; Hirama Y
    Jpn J Antibiot; 1976 Jul; 29(7):695-700. PubMed ID: 1048199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D; Schurig R; Weihermüller K; Förster D
    Antimicrob Agents Chemother; 1980 Jul; 18(1):81-7. PubMed ID: 6448024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antibacterial and pharmacokinetic actions of amoxicillin].
    Duval J; Soussy CJ
    Nouv Presse Med; 1975 Oct; 4(34):2433-6. PubMed ID: 812057
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis.
    Conte JE
    J Infect Dis; 1991 Jan; 163(1):169-75. PubMed ID: 1984463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency.
    Gehr TW; Rudy DW; Matzke GR; Kramer WG; Sica DA; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):31-8. PubMed ID: 8033492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetics of ampicillin in patients with chronic renal insufficiency during hemodialysis and hemosorption].
    Iakovlev VP; Skala LZ; Cherniakov VL; Shcherbakov VA; Shuster AM
    Antibiot Med Biotekhnol; 1985 May; 30(5):380-3. PubMed ID: 4026260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of cefalexin pharmacokinetics and dosage adjustments in relation to renal function.
    Brogard JM; Pinget M; Dorner M; Lavillaureix J
    J Clin Pharmacol; 1975 Oct; 15(10):666-73. PubMed ID: 1184770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency.
    Humbert G; Fillastre JP; Leroy A; Godin M; Van Winzum C
    Rev Infect Dis; 1979; 1(1):118-26. PubMed ID: 318213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patients.
    Aparicio M; Dratwa M; el Esper N; Fillastre JP; Levaltier B; Lins R; Meyrier A; Mignon F; Ryckelynck JP; Sennesael J
    Am J Cardiol; 1994 Dec; 74(13):43A-50A. PubMed ID: 7998585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.
    Rouan MC; Binswanger U; Bammatter F; Theobald W; Schoeller JP; Guibert J
    J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.